Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07316088
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
Sponsor: Florida State University
Conditions
PTSD Post Traumatic Stress Disorder
Interventions
OTX-003 Comparator app OTX-601 Digital Therapeutic
Updated 1 time since 2026 Last updated: Dec 31, 2025 Started: Dec 9, 2025 Primary completion: Mar 20, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2 trial investigates PTSD and Post Traumatic Stress Disorder and is currently actively recruiting participants. Florida State University leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Florida State University
- National Institute of Mental Health (NIMH)
- Oui Therapeutics, Inc.
Data source: Oui Therapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .